{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:37:14Z","timestamp":1792784234399,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T00:00:00Z","timestamp":1444780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Institute of Health\/National Cancer Institute","award":["P01CA084203"],"award-info":[{"award-number":["P01CA084203"]}]},{"name":"National Institute of Health\/National Cancer Institute","award":["K25CA164248"],"award-info":[{"award-number":["K25CA164248"]}]},{"name":"SYNERGY pilot award"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.pdpdt.2015.10.006","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T11:29:07Z","timestamp":1445772547000},"page":"561-566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2046-8298","authenticated-orcid":false,"given":"SC","family":"Kanick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SC","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KL","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EV","family":"Maytin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BW","family":"Pogue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MS","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pdpdt.2015.10.006_bib0005","first-page":"201","article-title":"Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications","volume":"87","author":"Feldman","year":"2011","journal-title":"Cutis"},{"key":"10.1016\/j.pdpdt.2015.10.006_bib0010","first-page":"CD004415","article-title":"Interventions for actinic keratoses","volume":"12","author":"Gupta","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pdpdt.2015.10.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2015.0502","article-title":"Long-term efficacy of topical fluorouracil cream, 5%, for treating actinic keratosis: a randomized clinical trial","author":"Pomerantz","year":"2015","journal-title":"JAMA Dermatol."},{"issue":"1","key":"10.1016\/j.pdpdt.2015.10.006_bib0020","first-page":"15","article-title":"Photodynamic therapy for actinic keratoses","volume":"25","author":"Kalisiak","year":"2007","journal-title":"DermatolClin."},{"issue":"1","key":"10.1016\/j.pdpdt.2015.10.006_bib0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1067\/mjd.2001.114288","article-title":"Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light","volume":"45","author":"Jeffes","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"issue":"Suppl 1","key":"10.1016\/j.pdpdt.2015.10.006_bib0030","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1080\/095466302317414663","article-title":"Levulan: the first approved topical photosensitizer for the treatment of actinic keratosis","volume":"13","author":"Jeffes","year":"2002","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"10.1016\/j.pdpdt.2015.10.006_bib0035","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1751-1097.2007.00276.x","article-title":"Photodynamic therapy in the treatment of actinic keratosis","volume":"84","author":"Stritt","year":"2008","journal-title":"Photochem. Photobiol."},{"issue":"1","key":"10.1016\/j.pdpdt.2015.10.006_bib0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaad.2006.06.006","article-title":"Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005","volume":"56","author":"Braathen","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"issue":"12","key":"10.1016\/j.pdpdt.2015.10.006_bib0045","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/jamadermatol.2014.1253","article-title":"Efficacy of photodynamic therapy vs other interventions in randomized clinical trials for the treatment of actinic keratoses: a systematic review and meta-analysis","volume":"150","author":"Patel","year":"2014","journal-title":"JAMA Dermatol."},{"issue":"1","key":"10.1016\/j.pdpdt.2015.10.006_bib0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archderm.140.1.41","article-title":"Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials","volume":"140","author":"Piacquadio","year":"2004","journal-title":"Arch Dermatol."},{"issue":"5","key":"10.1016\/j.pdpdt.2015.10.006_bib0055","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/00015550510032887","article-title":"A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp","volume":"85","author":"Tarstedt","year":"2005","journal-title":"Acta Derm. Venereol."},{"issue":"6","key":"10.1016\/j.pdpdt.2015.10.006_bib0060","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1365-2133.2006.07520.x","article-title":"Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up","volume":"155","author":"Tschen","year":"2006","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.pdpdt.2015.10.006_bib0065","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jaad.2012.05.039","article-title":"Short incubation photodynamic therapy with methylaminolevulinate and no occlusion for the treatment of actinic keratoses","volume":"67","author":"Bissonnette","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"issue":"5","key":"10.1016\/j.pdpdt.2015.10.006_bib0070","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-3083.2008.03029.x","article-title":"Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses","volume":"23","author":"Braathen","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.pdpdt.2015.10.006_bib0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archderm.140.1.33","article-title":"A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage","volume":"140","author":"Touma","year":"2004","journal-title":"Arch. Dermatol."},{"issue":"6","key":"10.1016\/j.pdpdt.2015.10.006_bib0080","first-page":"629","article-title":"Short incubation PDT versus 5-FU in treating actinic keratoses","volume":"2","author":"Smith","year":"2003","journal-title":"J. Drugs Dermatol."},{"issue":"4","key":"10.1016\/j.pdpdt.2015.10.006_bib0085","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.0022-202X.2005.23843.x","article-title":"Correlation between macroscopic fluorescence and protoporphyrin IX content in psoriasis and actinic keratosis following application of aminolevulinic acid","volume":"125","author":"Smits","year":"2005","journal-title":"J. Investig. Dermatol."},{"issue":"5","key":"10.1016\/j.pdpdt.2015.10.006_bib0090","doi-asserted-by":"crossref","first-page":"051607","DOI":"10.1117\/1.3484255","article-title":"Noninvasive fluorescence monitoring of protoporphyrin IX production and clinical outcomes in actinic keratoses following short-contact application of 5-aminolevulinate","volume":"15","author":"Warren","year":"2010","journal-title":"J. Biomed. Opt."},{"issue":"3","key":"10.1016\/j.pdpdt.2015.10.006_bib0095","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000353775","article-title":"Correlation between protoporphyrin IX fluorescence intensity, photobleaching, pain and clinical outcome of actinic keratosis treated by photodynamic therapy","volume":"227","author":"Piffaretti","year":"2013","journal-title":"Dermatology"},{"issue":"7","key":"10.1016\/j.pdpdt.2015.10.006_bib0100","doi-asserted-by":"crossref","first-page":"75002","DOI":"10.1117\/1.JBO.19.7.075002","article-title":"Dual-channel red\/blue fluorescence dosimetry with broadband reflectance spectroscopic correction measures protoporphyrin IX production during photodynamic therapy of actinic keratosis","volume":"19","author":"Kanick","year":"2014","journal-title":"J. Biomed. Opt."},{"issue":"3","key":"10.1016\/j.pdpdt.2015.10.006_bib0105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1011-1344(97)00076-6","article-title":"Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood","volume":"40","author":"Rick","year":"1997","journal-title":"J. Photochem. Photobiol. B"},{"issue":"2","key":"10.1016\/j.pdpdt.2015.10.006_bib0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1600-0781.2006.00202.x","article-title":"Characteristics of 5-aminolaevulinic acid-induced protoporphyrin IX fluorescence in human skin in vivo","volume":"22","author":"Ibbotson","year":"2006","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"issue":"2","key":"10.1016\/j.pdpdt.2015.10.006_bib0115","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s101030050032","article-title":"The monitoring of ALA-induced protoporphyrin IX accumulation and clearance in patients with skin lesions by in vivo surface-detected fluorescence spectroscopy","volume":"14","author":"Golub","year":"1999","journal-title":"Lasers Med. Sci."},{"issue":"4","key":"10.1016\/j.pdpdt.2015.10.006_bib0120","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2340\/00015555-0875","article-title":"Variation in epidermal morphology in human skin at different body sites as measured by reflectance confocal microscopy","volume":"90","author":"Robertson","year":"2010","journal-title":"Acta Derm. Venereol."},{"issue":"10","key":"10.1016\/j.pdpdt.2015.10.006_bib0125","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/01.DSS.0000452662.69539.57","article-title":"Temperature-modulated photodynamic therapy for the treatment of actinic keratosis on the extremities: a pilot study","volume":"40","author":"Willey","year":"2014","journal-title":"Dermatol. Surg."},{"issue":"1","key":"10.1016\/j.pdpdt.2015.10.006_bib0130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2012.07.026","article-title":"Biomodulatory approaches to photodynamic therapy for solid tumors","volume":"326","author":"Anand","year":"2012","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.pdpdt.2015.10.006_bib0135","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1562\/0031-8655(2002)076<0452:TEOAOP>2.0.CO;2","article-title":"Temperature effect on accumulation of protoporphyrin IX after topical application of 5-aminolevulinic acid and its methylester and hexylester derivatives in normal mouse skin","volume":"76","author":"Juzeniene","year":"2002","journal-title":"Photochem. Photobiol."},{"issue":"1","key":"10.1016\/j.pdpdt.2015.10.006_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jphotobiol.2010.12.011","article-title":"The effect of air cooling pain relief on protoporphyrin IX photobleaching and clinical efficacy during dermatological photodynamic therapy","volume":"103","author":"Tyrrell","year":"2011","journal-title":"J. Photochem. Photobiol. B"},{"issue":"3","key":"10.1016\/j.pdpdt.2015.10.006_bib0145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000183753","article-title":"Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy","volume":"218","author":"Gerritsen","year":"2009","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.pdpdt.2015.10.006_bib0150","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1346-8138.2008.00445.x","article-title":"Prospects for the use of differentiation-modulating agents as adjuvant of photodynamic therapy for proliferative dermatoses","volume":"35","author":"Akilov","year":"2008","journal-title":"J. Dermatol."},{"issue":"1","key":"10.1016\/j.pdpdt.2015.10.006_bib0155","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1046\/j.1365-2133.2003.05351.x","article-title":"The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy","volume":"149","author":"Choudry","year":"2003","journal-title":"Br. J. Dermatol."},{"issue":"10","key":"10.1016\/j.pdpdt.2015.10.006_bib0160","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1158\/1078-0432.CCR-08-3054","article-title":"Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo","volume":"15","author":"Anand","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"18","key":"10.1016\/j.pdpdt.2015.10.006_bib0165","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1158\/0008-5472.CAN-11-0805","article-title":"Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy","volume":"71","author":"Anand","year":"2011","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.pdpdt.2015.10.006_bib0170","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pdpdt.2010.09.005","article-title":"Protoporphyrin IX photobleaching during the light irradiation phase of standard dermatological methyl-aminolevulinate photodynamic therapy","volume":"7","author":"Tyrrell","year":"2010","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"7","key":"10.1016\/j.pdpdt.2015.10.006_bib0175","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/lsm.20943","article-title":"The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome","volume":"42","author":"Tyrrell","year":"2010","journal-title":"Lasers Surg. Med."},{"issue":"1","key":"10.1016\/j.pdpdt.2015.10.006_bib0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pdpdt.2010.12.008","article-title":"A review of pain experienced during topical photodynamic therapy\u2014our experience in Dundee","volume":"8","author":"Attili","year":"2011","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"1","key":"10.1016\/j.pdpdt.2015.10.006_bib0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1039\/c2pp25128k","article-title":"The relation between methyl aminolevulinate concentration and inflammation after photodynamic therapy in healthy volunteers","volume":"12","author":"Fabricius","year":"2013","journal-title":"Photochem. Photobiol. Sci."},{"issue":"3","key":"10.1016\/j.pdpdt.2015.10.006_bib0190","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/bjd.12562","article-title":"Prostaglandin E2 and nitric oxide mediate the acute inflammatory (erythemal) response to topical 5-aminolaevulinic acid photodynamic therapy in human skin","volume":"169","author":"Brooke","year":"2013","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.pdpdt.2015.10.006_bib0195","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/bjd.12495","article-title":"The acute inflammatory response to photodynamic therapy","volume":"169","author":"Ibbotson","year":"2013","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.pdpdt.2015.10.006_bib0200","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jaad.2009.03.048","article-title":"Pain associated with aminolevulinic acid-photodynamic therapy of skin disease","volume":"61","author":"Warren","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.pdpdt.2015.10.006_bib0205","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jaad.2009.08.062","article-title":"Factors influencing pain intensity during topical photodynamic therapy of complete cosmetic units for actinic keratoses","volume":"63","author":"Gholam","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"issue":"5","key":"10.1016\/j.pdpdt.2015.10.006_bib0210","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/bjd.12558","article-title":"Follow-up analysis of the efficacy of photodynamic therapy in actinic keratosis","volume":"169","author":"Kolde","year":"2013","journal-title":"Br. J. Dermatol."}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100015300387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100015300387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:24:52Z","timestamp":1761611092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100015300387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1572100015300387"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2015.10.006","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2015.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}